Clinical trialNCT01270841CompletedPhase 2Interventional

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

SponsorRepros Therapeutics Inc.Enrollment83Secondary Hypogonadism

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Purpose of the study is to determine the effects of Androxal on morning testosterone and reproductive status in men with secondary hypogonadism(confirmed morning Testosterone less than 250 ng/dL), compared to changes with placebo, or Testim (topical testosterone). The effects of Testim versus placebo on reproductive status will also be examined. Study subjects must not be currently using a topical testosterone.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Larry Lipshultz, MD
Baylor College of Medicine
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Paradigm Clinical Inc.
Garden Grove, California, United States
Northern California Research Corp
Sacramento, California, United States
Medical Center for Clinical Research
San Diego, California, United States
Los Angeles Biomedical Research Institute
Torrance, California, United States
Affiliated Clinical Research
Las Vegas, Nevada, United States
Affiliated Clinical Research Inc.
Las Vegas, Nevada, United States
Weill Cornell Medical College and Smith Institute
Great Neck, New York, United States
Jed Kaminetsky
New York, New York, United States
Natan Bar-Chama
New York, New York, United States
Michael A Werner
Purchase, New York, United States
Discovery Clinical Trials
Austin, Texas, United States
Research Across America
Carrollton, Texas, United States
Centex Research
Houston, Texas, United States
Endocrine and Psychiatry Center
Houston, Texas, United States
Texas Urology Specialist
Houston, Texas, United States
Protenium Clinical Research
Hurst, Texas, United States
R/d Clinical Research
Lake Jackson, Texas, United States
Cetero Research
San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AndroxalPlaceboTestosterone →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2011
Primary completion: 31 Dec 2011
Completion: 31 Dec 2011
Last update posted: 28 Jul 2014
Registered enrollment: 83
Registry id: NCT01270841

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.